Skip to content

Academic biography

A/Prof Mark Danta is a Clinical Academic Gastroenterologist and Associate Professor of Medicine at St Vincent’s Hospital and Faculty of Medicine, UNSW.

Through his post-graduate career in Sydney and London he has developed a broad skill set that has allowed him to collaborate, particularly in the translation from clinical medicine to the bench and vice versa. This has included: clinical medicine, laboratory-based virology and immunology research, qualitative methods and epidemiology.

His major focus has been HCV transmission, which has combined clinical and molecular epidemiology to characterise HCV transmission, particularly in the HIV infected population. He developed an interest in viral hepatitis during his research for his Master of Public Health, University of Sydney 2002. This led to a publication exploring fibrosis progression in HCV published in the Medical Journal of Australia, which had significant local impact. He completed his doctoral thesis on HCV transmission at the University of London in 2006. This was a combination of multifaceted work that led to a number of important publications in the area. It culminated in an international collaboration defining the transmission of HCV in HIV populations. These cited publications provided important data which have guided clinical recommendations such as the European AIDS Network (NEAT) and the British HIV Association guidelines (BHIVA). He consolidated this area as the principal investigator on a successful NHMRC project grant (568850) funded study, to explore HCV transmission in high-risk populations in Australia.

With the dramatic changing landscape of viral hepatitis therapies, his collaborative research evolved to include a clinical translational study of the gastrointestinal immune system and the study of cirrhosis and non-invasive assessment of liver fibrosis. He was a key member of the PINT study, exploring viral reservoirs in HIV infection in chronic and acute infection. He was the clinical interface for the development of the gastrointestinal protocols and performed all the clinical gastroenterology work. In collaboration with other researchers, he successfully obtained significant research funding, including Cancer Institute of NSW (CIB), NHMRC funding (CIB), UNSW Major Equipment grant (CIA), and ARC linkage grant (Associate Investigator). Most important of these is the development of research in vivo confocal endomicroscopy (CE) of the gastrointestinal tract and work in hepatocellular carcinoma. He now runs the Gastrointestinal, Liver and Microbiome Research at the St Vincent’s Applied Medical Research Centre, St Vincent’s Hospital.

He has been on the editorial board of Alimentary Pharmacology and Therapeutics since 2013 and regularly reviews manuscripts for a range of the highest impact peer-reviewed publications in his field, including Alimentary Pharmacology & Therapeutics 2009-, Clinical Infectious Diseases 2010-, European Journal of Gastroenterology and Hepatology 2009-, Journal of Hepatology 2017-, Gastroenterology 2009-, GUT 2004-, Hepatology 2010-, Journal of Gastroenterology and Hepatology 2009-.

He has reviewed grants for Faculty of Medicine, UNSW; Australian Research Council; Swiss National Science Foundation; Alberta Innovative Health Solution.

Publications and awards

In total, he has 54 papers and three book chapters with an H-index is 19. His citations are in excess of 2276, with 12 papers having more than 50 citations. He has received a number of awards including the inaugural St Vincent’s Clinical School Research Award 2011 and publication award 2014, 2016-18, Young Investigator Award, Conference on Retroviruses and Opportunistic Infections (CROI) 2006, University College London Peter Samuel Fellowships 2005 & 2006, Special Trustee Fellowship Royal Free and University College London 2004-5, Fellowship of Pathological Society of Great Britain 2003, British Association for the Study of Liver Travel Award 2003 and 2005, Best Oral Presentation British HIV Association 2004 and 2005.

Research funding

In total, he has obtained over $2 million in grant money, including both category 1 and category 2 funding. The majority of these are as CIA or CIB. As outlined, many of these projects are ongoing. In addition to the previous NHMRC grant, he currently has one NHMRC project grant (1066243) and a large Cancer NSW grant (1125702). He has also received substantial and varied funding from Cancer Institute NSW, UNSW, St Vincent’s Clinic Foundation, Curran Foundation, and the Australian Centre for HIV and Hepatitis Virology Research.

Teaching, mentoring and responsibilities

As Postgraduate Co-ordinator for St Vincent’s Clinical School and a member of the Higher Degree Committee since 2007. He is involved at all levels of teaching including undergraduate UNSW and postgraduate medical education. He has supervised PhD and Honours students at UNSW. Currently, he has three PhD student and one honours student. He is an examiner for the Royal Australasian College of Physicians (RACP).

Published papers:

Journal articles

Weber MF; Marshall HM; Rankin N; Duffy S; Fong KM; Dunlop K; Humphreys L; Smit AK; Cust AE; Taylor N, 2019, ‘Cancer screening in Australia: Future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers’, Public Health Research and Practice, vol. 29, http://dx.doi.org/10.17061/phrp2921910(link is external)

Dai P; Furlong T; Gracie G; Huang ML; Yang T; Wu KHC; Danta M; Wong M; Williams A; March L, 2019, ‘Autoinflammation Masquerading as Autoimmunity in an Adult with Heterozygous p.E250K PSTPIP1 Mutation’, Journal of Clinical Immunology, vol. 39, pp. 519 – 522, http://dx.doi.org/10.1007/s10875-019-00646-z(link is external)

Zaunders J; Dyer WB; Churchill M; Munier CML; Cunningham PH; Suzuki K; McBride K; Hey-Nguyen W; Koelsch K; Wang B, 2019, ‘Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.’, J Virus Erad, vol. 5, pp. 73 – 83, https://www.ncbi.nlm.nih.gov/pubmed/31191910(link is external)

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M, 2019, ‘A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015’, Journal of the International AIDS Society, vol. 22, http://dx.doi.org/10.1002/jia2.25222(link is external)

Cosorich I; McGuire HM; Warren J; Danta M; King C, 2019, ‘CCR9 expressing T helper and T follicular helper cells exhibit site-specific identities during inflammatory disease’, Frontiers in Immunology, vol. 10, http://dx.doi.org/10.3389/fimmu.2018.02899(link is external)

Lockart I; Matthews GV; Danta M, 2019, ‘Sexually transmitted hepatitis C infection: The evolving epidemic in HIV-positive and HIV-negative MSM’, Current Opinion in Infectious Diseases, vol. 32, pp. 31 – 37, http://dx.doi.org/10.1097/QCO.0000000000000515(link is external)

Chia XX; Cherepanoff S; Danta M; Furlong T, 2018, ‘Successful treatment of HCV-related glomerulonephritis with sofosbuvir and daclatasvir’, Nephrology, vol. 23, pp. 379 – 380, http://dx.doi.org/10.1111/nep.13087(link is external)

Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC, 2018, ‘Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency’, Journal of Clinical Immunology, vol. 38, pp. 159 – 162, http://dx.doi.org/10.1007/s10875-018-0477-z(link is external)

Ma CKK; Danta M; Day R; Ma DDF, 2018, ‘Dealing with the spiralling price of medicines: issues and solutions’, Internal Medicine Journal, vol. 48, pp. 16 – 24, http://dx.doi.org/10.1111/imj.13652(link is external)

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, ‘Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression’, Journal of Hepatology, vol. 67, pp. 1204 – 1212, http://dx.doi.org/10.1016/j.jhep.2017.07.025(link is external)

Newsum AM; Stolte IG; Van Der Meer JT; Schinkel J; Van Der Valk M; Vanhommerig JW; Buvé A; Danta M; Hogewoning A; Prins M, 2017, ‘Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM)’, Eurosurveillance, vol. 22, http://dx.doi.org/10.2807/1560-7917.ES.2017.22.21.30540(link is external)

Danta M; Barber DA; Zhang HP; Lee-Ng M; Baumgart SWL; Tsai VWW; Husaini Y; Saxena M; Marquis CP; Errington W, 2017, ‘Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia’, Alimentary Pharmacology and Therapeutics, vol. 46, pp. 347 – 354, http://dx.doi.org/10.1111/apt.14156(link is external)

Danta M; Ghinea N, 2017, ‘The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study.’, J Virus Erad, vol. 3, pp. 77 – 81, https://www.ncbi.nlm.nih.gov/pubmed/28435690(link is external)

Ghinea N; Lipworth W; Day R; Hill A; Dore GJ; Danta M, 2017, ‘Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries’, The Lancet, vol. 389, pp. 1268 – 1272, http://dx.doi.org/10.1016/S0140-6736(16)32051-7(link is external)

Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA, 2016, ‘CD4+ T follicular helper and IgA+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals’, Frontiers in Immunology, vol. 7, http://dx.doi.org/10.3389/fimmu.2016.00438(link is external)

Bradshaw D; Raghwani J; Jacka B; Sacks-Davis R; Lamoury F; Down I; Prestage G; Applegate TL; Hellard M; Sasadeusz J, 2016, ‘Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men’, PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0162002(link is external)

Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK, 2015, ‘Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.’, AIDS, vol. 29, pp. 911 – 919, http://dx.doi.org/10.1097/QAD.0000000000000625(link is external)

Bradshaw D; Lamoury F; Catlett B; Applegate TL; McAllister J; Dore GJ; Matthews GV; Danta M, 2015, ‘A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals’, Journal of Infectious Diseases, vol. 211, pp. 736 – 743, http://dx.doi.org/10.1093/infdis/jiu550(link is external)

Sasson S; Smith S; Sewell WA; Morey A; Danta M; Emmett L; Kelleher AD; Fay K; Phan T, 2014, ‘MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY’, INTERNAL MEDICINE JOURNAL, vol. 44, pp. 33 – 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Saxena A; Meteling B; Kapoor J; Golani S; Danta M; Morris DL; Bester L, 2014, ‘Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: A single centre experience of 45 consecutive patients’, International Journal of Surgery, vol. 12, pp. 1403 – 1408, http://dx.doi.org/10.1016/j.ijsu.2014.07.269(link is external)

Martinello M; Chow DH; Danta M; Matthews GV; Dore GJ, 2014, ‘Regression of advanced fibrosis following virological response to anti-HCV therapy’, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 29, pp. 85 – 85, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000166&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Danta M; Bradshaw D, 2014, ‘Editorial: Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B’, Alimentary Pharmacology and Therapeutics, vol. 40, pp. 982, http://dx.doi.org/10.1111/apt.12926(link is external)

Gett RM; Cooray AR; Gold D; Danta M, 2014, ‘Evaluating informed consent for colonoscopy’, Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 24, pp. 345 – 352, http://dx.doi.org/10.1097/SLE.0000000000000053(link is external)

Bradshaw D; Applegate T; Dore G; Hellard M; Sasadeusz J; Matthews G; Danta M, 2014, ‘The majority of acute HCV infection in HIV-positive men who have sex with men (HIV plus MSM) is transmitted permucosally in the context of HIV serosorting in Australia’, HIV MEDICINE, vol. 15, pp. 137 – 137, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333652300421&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Bradshaw D; Lamoury F; Catlett B; Mcallister J; Applegate T; Dore G; Matthews G; Danta M, 2014, ‘Seminal HCV RNA level may mirror dynamics of plasma HCV RNA in HIV-infected men with acute HCV’, HIV MEDICINE, vol. 15, pp. 8 – 8, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333652300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Bradshaw D; Danta M, 2014, ‘Commentary: Tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients’, Alimentary Pharmacology and Therapeutics, vol. 39, pp. 992, http://dx.doi.org/10.1111/apt.12675(link is external)

Bradshaw D; Matthews G; Danta M, 2013, ‘Sexually transmitted hepatitis C infection: The new epidemic in MSM?’, Current Opinion in Infectious Diseases, vol. 26, pp. 66 – 72, http://dx.doi.org/10.1097/QCO.0b013e32835c2120(link is external)

Danta M; Kim AY, 2012, ‘Hepatobiliary Diseases’, Hunter’s Tropical Medicine and Emerging Infectious Disease: Ninth Edition, pp. 28 – 34, http://dx.doi.org/10.1016/B978-1-4160-4390-4.00004-7(link is external)

Brown DA; Hance KW; Rogers CJ; Sansbury LB; Albert PS; Murphy G; Laiyemo AO; Wang Z; Cross AJ; Schatzkin A, 2012, ‘Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): A potential screening tool for the prevention of colon cancer?’, Cancer Epidemiology Biomarkers and Prevention, vol. 21, pp. 337 – 346, http://dx.doi.org/10.1158/1055-9965.EPI-11-0786(link is external)

Kumarasinghe G; Herrera C; Stuart S; Victor A; Amin J; Hayward C; MacDonald P; Danta M, 2011, ‘Noninvasive assessment of liver fibrosis in cardiac disease’, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 26, pp. 54 – 54, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000295157300141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Albert M; Benito J; Bhagani S; Boesecke C; Deterding K; Dominguez S; Fisher M; Fontanet A; Garcia D; Gilson R, 2011, ‘Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infecti’, AIDS, vol. 25, pp. 399 – 409, http://dx.doi.org/10.1097/QAD.0b013e328343443b(link is external)

Nattermann J; Vogel M; Nischalke HD; Danta M; Mauss S; Stellbrink HJ; Baumgarten A; Mayr C; Bruno R; Tural C, 2011, ‘Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C’, Journal of Infectious Diseases, vol. 203, pp. 595 – 601, http://dx.doi.org/10.1093/infdis/jiq098(link is external)

Danta M; Rodger AJ, 2011, ‘Transmission of HCV in HIV-positive populations’, Current Opinion in HIV and AIDS, vol. 6, pp. 451 – 458, http://dx.doi.org/10.1097/COH.0b013e32834b4974(link is external)

Cebreros CB; Danta MR, 2011, ‘Conjugacy and reciprocal bases in anisotropic dielectric media’, Optica Pura y Aplicada, vol. 44, pp. 571 – 580

Danta M; Kumarasinghe G; Stuart S; Victor A; Amin J; Hayward C; Macdonald P, 2010, ‘Liver elastography in cardiac disease (LECD) study’, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 25, pp. A24 – A25, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1(link is external)

Nischalke HD; Vogel M; Mauss S; Baumgarten A; Lutz T; Danta M; Naumann U; Coenen M; Sauerbruch T; Rockstroh JK, 2010, ‘The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection’, AIDS, vol. 24, pp. 2001 – 2007, http://dx.doi.org/10.1097/QAD.0b013e32833bedc8(link is external)

Van De Laar TJW; Matthews GV; Prins M; Danta M, 2010, ‘Acute hepatitis C in HIV-infected men who have sex with men: An emerging sexually transmitted infection’, AIDS, vol. 24, pp. 1799 – 1812, http://dx.doi.org/10.1097/QAD.0b013e32833c11a5(link is external)

Jones R; Nelson M; Low E; Atkins M; Asboe D; Brown D; Bhagani S; Dusheiko G; Danta M; Pybus O, 2010, ‘Re-emergent hepatitis C viremia after apparent clearance in HIV-positive men who have sex with men: Reinfection or late recurrence?’, Journal of Acquired Immune Deficiency Syndromes, vol. 53, pp. 547 – 550, http://dx.doi.org/10.1097/QAI.0b013e3181ba41e2(link is external)

Jones R; Brown D; Nelson M; Low E; Bhagani S; Atkins M; Danta M; Dusheiko G; Pybus O; Asboe D, 2010, ‘Erratum: Re-emergent hepatitis C viremia after apparent clearance in HIV-positive men who have sex with men: Reinfection or late recurrence (Journal of Acquired Immune Deficiency Syndromes (2010) 53 (‘, Journal of Acquired Immune Deficiency Syndromes, vol. 54, pp. 112, http://dx.doi.org/10.1097/QAI.0b013e3181cbd469(link is external)

Bellver-Cebreros C; Rodriguez-Danta M, 2009, ‘Analogies between the torque-free motion of a rigid body about a fixed point and light propagation in anisotropic media’, European Journal of Physics, vol. 30, pp. 285 – 294, http://dx.doi.org/10.1088/0143-0807/30/2/007(link is external)

van de Laar T; Pybus O; Bruisten S; Brown D; Nelson M; Bhagani S; Vogel M; Baumgarten A; Chaix ML; Fisher M, 2009, ‘Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men’, Gastroenterology, vol. 136, pp. 1609 – 1617, http://dx.doi.org/10.1053/j.gastro.2009.02.006(link is external)

Danta M; Dusheiko GM, 2008, ‘Acute HCV in HIV-positive individuals – A review’, Current Pharmaceutical Design, vol. 14, pp. 1690 – 1697, http://dx.doi.org/10.2174/138161208784746761(link is external)

Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U, 2008, ‘The transforming growth factor-β high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C’, AIDS, vol. 22, pp. 1287 – 1292, http://dx.doi.org/10.1097/QAD.0b013e3282f85daa(link is external)

Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P, 2008, ‘Impact of HIV on host-virus interactions during early hepatitis C virus infection’, Journal of Infectious Diseases, vol. 197, pp. 1558 – 1566, http://dx.doi.org/10.1086/587843(link is external)

Bellver-Cebreros C; Rodriguez-Danta M, 2007, ‘Alternative methods for ray tracing in uniaxial media. Application to negative refraction’, Optik, vol. 118, pp. 103 – 109, http://dx.doi.org/10.1016/j.ijleo.2005.12.016(link is external)

Danta M; Brown D; Bhagani S; Pybus OG; Sabin CA; Nelson M; Fisher M; Johnson AM; Dusheiko GM, 2007, ‘Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours’, AIDS, vol. 21, pp. 983 – 991, http://dx.doi.org/10.1097/QAD.0b013e3281053a0c(link is external)

Dusheiko G; Danta M, 2007, ‘Telbivudine for the treatment of chronic hepatitis B’, Drugs of Today, vol. 43, pp. 293 – 304, http://dx.doi.org/10.1358/dot.2007.43.5.1062671(link is external)

Nattermann J; Vogel M; Berg T; Danta M; Axel B; Mayr C; Bruno R; Tural C; Klausen G; Clotet B, 2007, ‘Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients’, Hepatology, vol. 46, pp. 1016 – 1025, http://dx.doi.org/10.1002/hep.21778(link is external)

Danta M, 2007, ‘Reply’, Gastroenterology, vol. 133, pp. 1736 – 1737, http://dx.doi.org/10.1053/j.gastro.2007.09.041(link is external)

Bellver-Cebreros C; Rodriguez-Danta M, 2006, ‘Amphoteric refraction at the isotropic-anisotropic biaxial media interface: An alternative treatment’, Journal of Optics A: Pure and Applied Optics, vol. 8, pp. 1067 – 1073, http://dx.doi.org/10.1088/1464-4258/8/12/006(link is external)

Dusheiko G; Danta M, 2005, ‘Can Peg-IFN α-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?’, Nature Clinical Practice Gastroenterology and Hepatology, vol. 2, pp. 130 – 131, http://dx.doi.org/10.1038/ncpgasthep0117(link is external)

Danta M; Barnes E; Dusheiko G, 2005, ‘The surveillance and diagnosis of hepatocellular carcinoma’, European Journal of Gastroenterology and Hepatology, vol. 17, pp. 491 – 496, http://dx.doi.org/10.1097/00042737-200505000-00004(link is external)

Ng C; Danta M; Kellow J; Badcock CA; Hansen R; Malcolm A, 2005, ‘Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome’, American Journal of Physiology – Gastrointestinal and Liver Physiology, vol. 289, http://dx.doi.org/10.1152/ajpgi.00527.2004(link is external)

Danta M; Dusheiko G, 2004, ‘Adefovir dipivoxil: Review of a novel acyclic nucleoside analogue’, International Journal of Clinical Practice, vol. 58, pp. 877 – 886, http://dx.doi.org/10.1111/j.1742-1241.2004.00364.x(link is external)

Ng C; Danta M; Prott G; Badcock CA; Kellow J; Malcolm A, 2004, ‘Modulatory influences on antegrade and retrograde tonic reflexes in the colon and rectum’, American Journal of Physiology – Gastrointestinal and Liver Physiology, vol. 287, http://dx.doi.org/10.1152/ajpgi.00460.2003(link is external)

Danta M, 2003, ‘Positive hepatitis B serology with normal liver function tests’, Medicine Today, vol. 4, pp. 58

Danta M; Dore GJ; Hennessy L; Li Y; Vickers CR; Harley H; Ngu M; Reed W; Desmond PV; Sievert W, 2002, ‘Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection’, Medical Journal of Australia, vol. 177, pp. 240 – 245

Bellver-Cebreros C; Rodriguez-Danta M, 2002, ‘Internal conical refraction in biaxial media and graphical plane constructions deduced from Möhr’s method’, Optics Communications, vol. 212, pp. 199 – 210, http://dx.doi.org/10.1016/S0030-4018(02)02009-6(link is external)

Bellver-Cebreros C; Rodriguez-Danta M, 2001, ‘Eikonal equation, alternative expression of Fresnel’s equation and Möhr’s construction in optical anisotropic media’, Optics Communications, vol. 189, pp. 193 – 209, http://dx.doi.org/10.1016/S0030-4018(01)01028-8(link is external)

Bellver-Cebreros C; Rodriguez-Danta M; Gomez-Gonzalez E, 2000, ‘Angle eikonal from reciprocal action and other optical-mechanical analogues’, Optik (Jena), vol. 111, pp. 261 – 268

Bellver-Cebreros C; Rodriguez-Danta M, 1992, ‘Caustics and the Legendre transform’, Optics Communications, vol. 92, pp. 187 – 192, http://dx.doi.org/10.1016/0030-4018(92)90619-3(link is external)

Myers S; Drinkwater A; Davis S; Jantz P; Danta M; Lane J; Wickens S; Liew E; Everingham S, 1990, ‘Alcohol consumption awareness in young male drivers’, Medical Journal of Australia, vol. 152, pp. 503

Invited presentations:

  • 2009 Journal of Gastroenterology and Hepatology
  • 2009- Gastroenterology
  • 2009- Parasitology
  • 2008- Haemophilia
  • 2007- European Journal of Gastroenterology and Hepatology
  • Drugs 2004-2006 Alcoholism: Clinical and Experimental Research 2006- International Journal of Parasitology
  • 2006 Physician Research Network, New York: Acute HCV in HIV co-infection
  • 2005 BHIVA, London: HCV- A phylogenetic approach to a new epidemic
  • 2005 Sheila Sherlock Hepatology Update, London
  • 2004 UEGW, Prague: The use of erythropoeitin in HCV (Contra)
  • 2004 Exeter: Management of HCV/HIV Co-infection
  • 2003 Sheila Sherlock Hepatology Update, London
  • 2004 Journal Reviewer GUT
Scroll To Top